STUDIO
Follow Us

Terms of Use Privacy Policy

Bayer Exploring Sale of Diabetes Unit for Up to $2.5B

Nov. 24 (Bloomberg) -- Bayer is exploring the sale of its diabetes device business as the German company focuses on faster-growing medicines. Julie Hyman reports on “Street Smart.” (Source: Bloomberg)

Source: Bloomberg

Top Trending Videos